Related Experiment Video
Updated: Sep 15, 2025
Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
Published on: March 8, 2015
Exploring the efficacy of deep brain stimulation in pediatric neurological disorders: a comprehensive review
Tianshuang Wang1, Xinhua Wang1, Yi Wang1
1Department of Neurology, Children's Hospital of Fudan University, National Children's Medical Center, No.399 Wanyuan Road, Minhang District, Shanghai, 201102, P. R. China.
Insights
Deep brain stimulation (DBS) shows potential for treating pediatric neurological disorders like epilepsy and Tourette syndrome. However, current data is limited, necessitating further research to confirm efficacy and safety in children.
Area of Science:
- Neurology
- Pediatric Medicine
- Neurosurgery
Background:
- Deep brain stimulation (DBS) is a validated therapy for drug-resistant neurological and psychiatric disorders in adults.
- A significant knowledge gap exists regarding DBS application in pediatric populations.
- Pediatric patients with severe dystonia, epilepsy, Tourette syndrome, and other conditions urgently need alternative treatments.
Purpose of the Study:
- To systematically review the existing literature on DBS application in pediatric neurological disorders.
- To focus on conditions including dystonia, drug-resistant epilepsy, and Tourette syndrome.
- To assess the potential efficacy, safety, and limitations of DBS in children.
Main Methods:
- Systematic literature review.
- Analysis of reported cases and outcomes in pediatric patients undergoing DBS.
- Evaluation of therapeutic success and adverse events.
Main Results:
- DBS demonstrates potential therapeutic benefits for a subset of pediatric patients.
- Current data is limited, lacking statistical power for definitive conclusions.
- Reported cases show variable degrees of therapeutic success.
- Adverse effects of DBS in pediatric populations appear rare but require further investigation.
Conclusions:
- DBS holds promise as a treatment option for specific pediatric neurological conditions.
- Further large-scale, randomized controlled trials are essential.
- Future research should focus on validating outcomes and establishing optimal patient selection criteria for pediatric DBS.
Abstract:
Deep brain stimulation (DBS) has emerged as an important therapeutic intervention, effectively addressing a spectrum of drug-resistant neurological and psychiatric disorders. Although its efficacy has been validated in adult populations, the current literature reveals a significant gap concerning its application in pediatric patients. Specifically, pediatric populations afflicted with severe conditions such as dystonia, drug-resistant epilepsy, Tourette syndrome, and some other neuropsychiatric conditions demonstrate an urgent need for alternative therapeutic options. This review systematically examined the existing literature on the application of DBS in pediatric neurological disorders, focusing on the aforementioned conditions. Preliminary findings indicate that while DBS shows potential for a specific subset of pediatric patients, the current data is limited and lacks statistical power. Reported cases exhibit varying degrees of therapeutic success. Although adverse effects associated with DBS in pediatric populations are rare, further investigation is essential to define safety profiles accurately. Future research should focus on conducting large-scale, randomized controlled trials to validate outcomes and determine optimal patient selection criteria, thereby broadening its clinical application within the pediatric population.
